New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.
about
Treatment for osteoporosis in people with ß-thalassaemiaTreatment for osteoporosis in people with ß-thalassaemiaMolecular Aspects of Bone Resorption in β-Thalassemia MajorChronic iron deficiency as an emerging risk factor for osteoporosis: a hypothesisAtypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literatureTreatment of multiple myeloma bone disease: experimental and clinical data.Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.Virtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes.Bone density in transfusion dependent thalassemia patients in Urmia, Iran.Iron Deficiency Anemia as a Risk Factor for Osteoporosis in Taiwan: A Nationwide Population-Based Study.Thalassaemia is a tropical disease.Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosisOsteoporosis syndrome in thalassaemia major: an overview.Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channelsZinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.Predictors of osteoclast activity in patients with sickle cell diseaseEndocrine and bone complications in β-thalassemia intermedia: current understanding and treatmentPhysiopathology of Bone Modifications in β-Thalassemia.Evaluation of Glutathione-S-Transferase P1 Polymorphism and its Relation to Bone Mineral Density in Egyptian Children and Adolescents with Beta-Thalassemia MajorHormonal and cytokine implications in the pathophysiology of osteoporosis occurring in chronic liver diseases.Vitamin D Receptor (VDR) Gene Polymorphisms (FokI, BsmI) and their Relation to Vitamin D Status in Pediatrics βeta Thalassemia Major.The thalassaemia syndromes.The ability of lumbar spine DXA and phalanx QUS to detect previous fractures in young thalassemic patients with hypogonadism, hypothyroidism, diabetes, and hepatitis-B: A 2-year subgroup analysis from the Taranto Area of Apulia Region.Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.Microelements for bone boost: the last but not the least.Beta-thalassemia.Association factor analysis between osteoporosis with cerebral artery disease: The STROBE study.Bleeding disorders and reduced bone density.The surgeon and the patient with β-thalassaemia intermedia.Iron homeostasis in osteoporosis and its clinical implications.Causes, mechanisms and management of paediatric osteoporosis.Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.The importance of nutrition for health in patients with transfusion-dependent thalassemia.Management of beta-thalassemia-associated osteoporosis.Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.Which pamidronate protocol is the best for treating osteoporosis in beta-thalassemia major?Refractive errors and ocular biometry components in thalassemia major patients.Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.Endocrine and metabolic disorders in β-thalassemiamajor patients.
P2860
Q24186036-BCFEEAC5-2A6C-4A5F-86B2-502BE3BB3971Q24200472-931C5D7F-9A6E-45FD-B478-2596ADFE7627Q26801066-DBD6FE73-E8AD-4FF6-A6FA-A98FA2BB1ED9Q26825199-9C82A2A8-33C4-42B6-AD5E-A48060820DD4Q28071432-F275CF29-C802-4D8F-AEC8-E04B50DBF715Q30868833-A251E9D6-5AC3-4732-A299-2D6A288EF68AQ33307072-D410F06F-4BF2-4484-BD11-BF749940D58CQ33508859-17CCD250-7CB8-4F07-B040-C9129D7F2EC0Q33850994-A7A30575-75A0-497A-8280-E290ADCA4493Q33852114-31A525C1-FE65-421E-BB89-B03F1387432AQ33950343-62B0B053-0C62-4A40-965A-EB2C8DAB1DBBQ34069299-8B1BBD55-21D9-45D5-AD0A-7C170FA4C1FDQ34211460-C362F8AC-9E52-461B-9EC8-DA09B169A0CBQ34649067-AA39B0C6-F243-4B93-929E-7E86AB15C21AQ34941788-E1945354-BDE8-4E9C-A777-D1F3B7BDFAC7Q35143450-C1A4534C-AA2F-4428-B0CA-6E0930D08553Q35193628-7997AFB0-D9D8-492F-BD90-761E9FF1DB55Q36014282-21038BBD-6282-4392-B0ED-3C86DC49411EQ36417569-772E3E45-0D27-4F71-BC86-4CF550B7F99BQ36671314-FE931901-C196-467E-A161-89D8D8B8FAE7Q36679586-3E398329-0936-40D9-8978-90364F66BE9AQ36762089-478DFC1E-DB01-4D12-B143-7CB4CDA14D87Q37156694-4422FDB5-BCBF-46E2-B5B0-895DE6E715BEQ37175616-4B31F03C-F1F7-4BDC-B652-EB50A7C181E5Q37653242-7F6AEA22-D426-48D2-98AC-133D0F5E4D8CQ37680651-8DF81A6B-4151-4710-A99F-53D16486BC99Q37684898-11BA1646-DD0C-4A0E-BA48-F5D574558264Q37761063-ABACE396-26CE-45DA-8341-2C2974B081E5Q37863611-C090167D-7F7B-4AB0-BFA5-C8F88E5B0692Q38004771-EBBB3ED2-0FA3-4E31-B77F-04A86A22103AQ38099517-AA3FF162-9521-40C1-9F4E-1C4347BBCF60Q38205707-F83666A9-0BB2-4592-93A5-DECFA7542C41Q38471926-81DC4F03-54C0-4083-9CA7-9D95D39430EAQ38715841-E32108FB-117E-494D-8885-9B636BB93AC3Q38802918-2C788B30-F096-4877-A9E0-82F3F6874DC2Q39260488-30D64134-904B-4657-82EE-F1A5B30D67EBQ40248622-FB5904F8-0CFA-41A8-A87A-086E1C8855B7Q41066623-DFF54BDE-C756-4E9A-95DA-F52A489215A7Q41608002-B287908B-B33F-4C06-868D-74ECD654F83BQ41836924-94A55A53-897E-48F7-B2F9-9B9748F1FECC
P2860
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
New insights into the pathophy ...... tients with beta thalassaemia.
@ast
New insights into the pathophy ...... tients with beta thalassaemia.
@en
type
label
New insights into the pathophy ...... tients with beta thalassaemia.
@ast
New insights into the pathophy ...... tients with beta thalassaemia.
@en
prefLabel
New insights into the pathophy ...... tients with beta thalassaemia.
@ast
New insights into the pathophy ...... tients with beta thalassaemia.
@en
P2860
P921
P1476
New insights into the pathophy ...... tients with beta thalassaemia.
@en
P2093
Ersi Voskaridou
Evangelos Terpos
P2860
P304
P356
10.1111/J.1365-2141.2004.05143.X
P407
P577
2004-10-01T00:00:00Z